Chantonnay, France

Régis Brion

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Chu Nantes, National Institute of Health and Medical Research, The University of Nantes. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Régis Brion. Retrieved from https://idiyas.com/inventor/régis-brion

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Régis Brion

Introduction

Régis Brion is a notable inventor based in Chantonnay, France. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. His work focuses on innovative solutions that address critical health issues.

Latest Patents

Régis Brion holds a patent for anti IL-34 antibodies. This patent pertains to novel anti IL-34 antibodies or antigen-binding fragments that specifically bind to the cytokine IL-34 with high affinity. The patent also details the methods for obtaining these antibodies and their therapeutic applications.

Career Highlights

Throughout his career, Régis Brion has worked with esteemed institutions such as Chu Nantes and the University of Nantes. His experience in these organizations has allowed him to advance his research and contribute to the scientific community.

Collaborations

Régis Brion has collaborated with notable colleagues, including Dominique Heymann and Aude Segaliny. These partnerships have fostered a collaborative environment that enhances research and innovation.

Conclusion

Régis Brion's work in developing anti IL-34 antibodies exemplifies his commitment to advancing medical science. His contributions are significant in the field of biotechnology and demonstrate the impact of innovative research on healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…